首页 > 最新文献

International Journal of General Medicine最新文献

英文 中文
Receptor-Interacting Protein Kinase 3 as a Serological Biomarker in Relation to Disease Severity and Delirium After Acute Pancreatitis: A Prospective Cohort Study. 受体相互作用蛋白激酶 3 作为血清生物标记物与急性胰腺炎后疾病严重程度和谵妄的关系:一项前瞻性队列研究
IF 2.1 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-15 eCollection Date: 2024-01-01 DOI: 10.2147/IJGM.S488540
Xiaorong Ye, Bingzhen Li, Fang Xu, Debiao Pan, Jing Wu

Objective: Delirium is a common complication of acute pancreatitis. Receptor-interacting protein kinase 3 (RIP3) is an activator of programmed cell necrosis. This study aimed to determine its ability to predict delirium after acute pancreatitis.

Methods: In total, 297 patients with acute pancreatitis were prospectively enrolled in this study. Patients were divided into two subgroups (study and validation groups: 197 and 100 cases, respectively). Serum RIP3 levels were measured in all patients and in 100 healthy controls. Acute Physiology and Chronic Health Evaluation (APACHE) II, Ranson, and sequential organ failure assessment (SOFA) scores were used for the severity assessment. In-hospital delirium was observed as an outcome variable. Multifactorial analyses were performed to discern severity correlations and outcome associations.

Results: Serum RIP3 levels were significantly higher in the patients than in the controls. Serum RIP3 levels had linear relationships under the restricted cubic spline and were independently correlated with APACHE II, Ranson, and SOFA scores. Serum RIP3 levels were linearly correlated with the likelihood of developing in-hospital delirium and exhibited a strong discrimination efficiency under the receiver operating characteristic curve. Serum RIP3 levels, coupled with APACHE II scores, Ranson scores, and SOFA scores, were the four independent predictors of in-hospital delirium. No interactions were revealed regarding its relevance to sex, age, or body mass index in subgroup analysis. These were integrated to form a model graphically represented by a nomogram that showed effective stability, clinical fit, and predictive ability for in-hospital delirium. The model was verified in the validation group.

Conclusion: An incremental trend in serum RIP3 levels was notable after acute pancreatitis. Serum RIP3 levels are independently related to illness severity and occurrence of in-hospital delirium, indicating that serum RIP3 may be a potential biomarker of acute pancreatitis.

目的:谵妄是急性胰腺炎的常见并发症:谵妄是急性胰腺炎的常见并发症。受体相互作用蛋白激酶 3 (RIP3) 是程序性细胞坏死的激活剂。本研究旨在确定其预测急性胰腺炎后谵妄的能力:本研究共招募了 297 名急性胰腺炎患者。患者被分为两个亚组(研究组和验证组:分别为 197 例和 100 例)。对所有患者和 100 名健康对照者的血清 RIP3 水平进行了测定。严重程度评估采用急性生理学和慢性健康评估(APACHE)II、Ranson 和序贯器官衰竭评估(SOFA)评分。院内谵妄作为一个结果变量进行观察。进行多因素分析以确定严重程度相关性和结果关联性:结果:患者血清 RIP3 水平明显高于对照组。血清 RIP3 水平在受限立方样条线下呈线性关系,并与 APACHE II、Ranson 和 SOFA 评分独立相关。血清 RIP3 水平与发生院内谵妄的可能性呈线性相关,在接收者操作特征曲线下表现出很强的区分效率。血清 RIP3 水平与 APACHE II 评分、Ranson 评分和 SOFA 评分是院内谵妄的四个独立预测因子。在亚组分析中,未发现其与性别、年龄或体重指数的相互作用。这些因素整合后形成了一个以提名图表示的模型,该模型显示出有效的稳定性、临床拟合度和对院内谵妄的预测能力。该模型在验证组中得到了验证:结论:急性胰腺炎发生后,血清 RIP3 水平呈显著上升趋势。血清RIP3水平与病情严重程度和院内谵妄的发生独立相关,表明血清RIP3可能是急性胰腺炎的潜在生物标志物。
{"title":"Receptor-Interacting Protein Kinase 3 as a Serological Biomarker in Relation to Disease Severity and Delirium After Acute Pancreatitis: A Prospective Cohort Study.","authors":"Xiaorong Ye, Bingzhen Li, Fang Xu, Debiao Pan, Jing Wu","doi":"10.2147/IJGM.S488540","DOIUrl":"10.2147/IJGM.S488540","url":null,"abstract":"<p><strong>Objective: </strong>Delirium is a common complication of acute pancreatitis. Receptor-interacting protein kinase 3 (RIP3) is an activator of programmed cell necrosis. This study aimed to determine its ability to predict delirium after acute pancreatitis.</p><p><strong>Methods: </strong>In total, 297 patients with acute pancreatitis were prospectively enrolled in this study. Patients were divided into two subgroups (study and validation groups: 197 and 100 cases, respectively). Serum RIP3 levels were measured in all patients and in 100 healthy controls. Acute Physiology and Chronic Health Evaluation (APACHE) II, Ranson, and sequential organ failure assessment (SOFA) scores were used for the severity assessment. In-hospital delirium was observed as an outcome variable. Multifactorial analyses were performed to discern severity correlations and outcome associations.</p><p><strong>Results: </strong>Serum RIP3 levels were significantly higher in the patients than in the controls. Serum RIP3 levels had linear relationships under the restricted cubic spline and were independently correlated with APACHE II, Ranson, and SOFA scores. Serum RIP3 levels were linearly correlated with the likelihood of developing in-hospital delirium and exhibited a strong discrimination efficiency under the receiver operating characteristic curve. Serum RIP3 levels, coupled with APACHE II scores, Ranson scores, and SOFA scores, were the four independent predictors of in-hospital delirium. No interactions were revealed regarding its relevance to sex, age, or body mass index in subgroup analysis. These were integrated to form a model graphically represented by a nomogram that showed effective stability, clinical fit, and predictive ability for in-hospital delirium. The model was verified in the validation group.</p><p><strong>Conclusion: </strong>An incremental trend in serum RIP3 levels was notable after acute pancreatitis. Serum RIP3 levels are independently related to illness severity and occurrence of in-hospital delirium, indicating that serum RIP3 may be a potential biomarker of acute pancreatitis.</p>","PeriodicalId":14131,"journal":{"name":"International Journal of General Medicine","volume":"17 ","pages":"5309-5323"},"PeriodicalIF":2.1,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11577434/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142681660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Treatment with Xinfeng Capsule Can Reduce the Risk of Readmission for Patients with Rheumatoid arthritis:A Cohort Study of Approximately 10000 Individuals. 新风胶囊可降低类风湿关节炎患者的再入院风险:一项约 10000 人的队列研究。
IF 2.1 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-15 eCollection Date: 2024-01-01 DOI: 10.2147/IJGM.S491218
Fanfan Wang, Jian Liu, Yanyan Fang, Yue Sun, Mingyu He

Objective: The present study aimed to investigate the potential association between the treatment with Xinfeng Capsule (XFC) and the risk of readmission among patients with rheumatoid arthritis (RA).

Methods: Through a retrospective approach, data were collected from all hospitalized patients diagnosed with RA at the First Affiliated Hospital of Anhui University of Chinese Medicine between 2013 and 2021. To mitigate selection bias and confounding factors, patients were stratified into an XFC group and a Non-XFC (Non-XFC) group based on their treatment status using propensity score matching with a 1:2 ratio. Variables such as age, gender, and baseline medications were adjusted. Subsequently, the Cox proportional hazards model was employed to calculate the hazard ratio (HR) for readmission among RA patients, while Kaplan-Meier curves were utilized to depict the incidence of readmission.

Results: A total of 9987 RA patients were included in this study. Following rigorous inclusion/exclusion criteria and propensity score matching, the XFC group comprised 2036 patients, while the Non-XFC group contained 4072 patients. The Cox proportional hazards model analysis revealed that XFC acted as a protective factor, significantly reducing the risk of readmission among RA patients. Further examination of Kaplan-Meier curves demonstrated that XFC use not only effectively lowered the frequency of readmissions but also exhibited a more pronounced effect in diminishing the risk of readmission with extended usage durations (beyond 12 months). Additionally, association rule analysis underscored the strong link between XFC and freedom from readmission, as well as the robust correlation between XFC usage and significant improvements in multiple laboratory indicators, including C3, C4, CRP, ESR, and others.

Conclusion: This study underscores a robust and long-term association between XFC usage and lower readmission rates among RA patients. As a protective factor against readmission risk in these patients, the clinical value of XFC merits further promotion and investigation.

研究目的本研究旨在探讨新风胶囊(XFC)治疗与类风湿关节炎(RA)患者再入院风险之间的潜在关联:通过回顾性方法,收集了2013年至2021年间安徽中医药大学第一附属医院所有确诊为RA的住院患者的数据。为减少选择偏倚和混杂因素,根据患者的治疗状态,采用倾向得分匹配法,以1:2的比例将患者分为XFC组和非XFC(非XFC)组。对年龄、性别和基线药物等变量进行了调整。随后,采用 Cox 比例危险模型计算 RA 患者再入院的危险比(HR),并利用 Kaplan-Meier 曲线描述再入院的发生率:本研究共纳入了 9987 名 RA 患者。经过严格的纳入/排除标准和倾向得分匹配,XFC 组有 2036 名患者,而非 XFC 组有 4072 名患者。Cox 比例危险模型分析显示,XFC 是一种保护因素,能显著降低 RA 患者的再入院风险。对 Kaplan-Meier 曲线的进一步研究表明,使用 XFC 不仅能有效降低再入院的频率,而且随着使用时间的延长(超过 12 个月),在降低再入院风险方面的效果更加明显。此外,关联规则分析强调了XFC与避免再入院之间的紧密联系,以及XFC的使用与C3、C4、CRP、ESR等多项实验室指标的显著改善之间的紧密相关性:本研究强调了使用 XFC 与降低 RA 患者再入院率之间的长期稳健联系。作为降低这些患者再入院风险的保护因素,XFC 的临床价值值得进一步推广和研究。
{"title":"The Treatment with Xinfeng Capsule Can Reduce the Risk of Readmission for Patients with Rheumatoid arthritis:A Cohort Study of Approximately 10000 Individuals.","authors":"Fanfan Wang, Jian Liu, Yanyan Fang, Yue Sun, Mingyu He","doi":"10.2147/IJGM.S491218","DOIUrl":"10.2147/IJGM.S491218","url":null,"abstract":"<p><strong>Objective: </strong>The present study aimed to investigate the potential association between the treatment with Xinfeng Capsule (XFC) and the risk of readmission among patients with rheumatoid arthritis (RA).</p><p><strong>Methods: </strong>Through a retrospective approach, data were collected from all hospitalized patients diagnosed with RA at the First Affiliated Hospital of Anhui University of Chinese Medicine between 2013 and 2021. To mitigate selection bias and confounding factors, patients were stratified into an XFC group and a Non-XFC (Non-XFC) group based on their treatment status using propensity score matching with a 1:2 ratio. Variables such as age, gender, and baseline medications were adjusted. Subsequently, the Cox proportional hazards model was employed to calculate the hazard ratio (HR) for readmission among RA patients, while Kaplan-Meier curves were utilized to depict the incidence of readmission.</p><p><strong>Results: </strong>A total of 9987 RA patients were included in this study. Following rigorous inclusion/exclusion criteria and propensity score matching, the XFC group comprised 2036 patients, while the Non-XFC group contained 4072 patients. The Cox proportional hazards model analysis revealed that XFC acted as a protective factor, significantly reducing the risk of readmission among RA patients. Further examination of Kaplan-Meier curves demonstrated that XFC use not only effectively lowered the frequency of readmissions but also exhibited a more pronounced effect in diminishing the risk of readmission with extended usage durations (beyond 12 months). Additionally, association rule analysis underscored the strong link between XFC and freedom from readmission, as well as the robust correlation between XFC usage and significant improvements in multiple laboratory indicators, including C3, C4, CRP, ESR, and others.</p><p><strong>Conclusion: </strong>This study underscores a robust and long-term association between XFC usage and lower readmission rates among RA patients. As a protective factor against readmission risk in these patients, the clinical value of XFC merits further promotion and investigation.</p>","PeriodicalId":14131,"journal":{"name":"International Journal of General Medicine","volume":"17 ","pages":"5285-5298"},"PeriodicalIF":2.1,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11575443/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142675768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serum Irisin Levels are Inversely Correlated with Acute Ischaemic Stroke Incidence: Implications for Early Diagnosis in Southern China. 血清鸢尾素水平与急性缺血性脑卒中发病率成反比:中国南方地区早期诊断的意义》。
IF 2.1 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-15 eCollection Date: 2024-01-01 DOI: 10.2147/IJGM.S483793
Fengshan Ouyang, Sheng Chen, Shuhuan Li, Lanyuan Liu, Senhong Guan, Zhaohan Yan, Shumin Wu, Yunying Zeng, Jiemei Liu, Jiankai Zhong

Objective: This study aimed to examine the correlation and prognostic value of serum irisin levels in acute ischaemic stroke (AIS) and the subsequent development of hemiplegia.

Methods: This study recruited participants from the Department of Neurology and Rehabilitation Medicine at Shunde Hospital, Southern Medical University. The Fugl-Meyer Assessment was used to assess functional impairment. Serum irisin levels were measured using the enzyme-linked immunosorbent assay method. Multivariate logistic regression was employed to explore the factors related to serum irisin levels and AIS.

Results: Serum irisin levels in the AIS group were significantly lower than those in the control group. However, no significant association was observed between serum irisin and stroke severity within the AIS cohort. Multivariate logistic regression analysis revealed an inverse correlation between serum irisin levels and AIS risk, indicating that it serves as a protective factor against AIS. The increase in serum irisin levels (adjusted odds ratio (OR) 0.938, 95% confidence interval [CI]: 0.899-0.977 per 100 pg/mL increment) was associated with a decreased risk of AIS. Analysis of the receiver operating characteristic curve confirmed the diagnostic value of serum irisin for AIS, with the area under the curve being 0.591 (95% CI: 0.522-0.659, p = 0.012).

Conclusion: Serum irisin levels were significantly lower in AIS and were identified as a protective factor, suggesting that serum irisin may have diagnostic value for AIS.

研究目的本研究旨在探讨血清鸢尾素水平与急性缺血性脑卒中(AIS)及其后偏瘫发生的相关性和预后价值:本研究招募了南方医科大学顺德医院神经内科和康复医学科的参与者。采用 Fugl-Meyer 评估法评估功能障碍。采用酶联免疫吸附法测定血清鸢尾素水平。采用多变量逻辑回归法探讨与血清鸢尾素水平和 AIS 相关的因素:结果:AIS 组的血清鸢尾素水平明显低于对照组。结果:AIS 组血清鸢尾素水平明显低于对照组,但在 AIS 组群中,血清鸢尾素与中风严重程度无明显关联。多变量逻辑回归分析表明,血清鸢尾素水平与 AIS 风险呈反相关,表明鸢尾素是 AIS 的保护因素。血清鸢尾素水平的升高(调整后的几率比(OR)为 0.938,95% 置信区间 [CI]:0.899-0.977)可降低 AIS 风险:每 100 pg/mL 的增量为 0.899-0.977)与 AIS 风险的降低有关。接收器操作特征曲线分析证实了血清鸢尾素对 AIS 的诊断价值,曲线下面积为 0.591(95% CI:0.522-0.659,P = 0.012):结论:血清鸢尾素水平在 AIS 中明显较低,被认为是一个保护因素,这表明血清鸢尾素可能对 AIS 有诊断价值。
{"title":"Serum Irisin Levels are Inversely Correlated with Acute Ischaemic Stroke Incidence: Implications for Early Diagnosis in Southern China.","authors":"Fengshan Ouyang, Sheng Chen, Shuhuan Li, Lanyuan Liu, Senhong Guan, Zhaohan Yan, Shumin Wu, Yunying Zeng, Jiemei Liu, Jiankai Zhong","doi":"10.2147/IJGM.S483793","DOIUrl":"10.2147/IJGM.S483793","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to examine the correlation and prognostic value of serum irisin levels in acute ischaemic stroke (AIS) and the subsequent development of hemiplegia.</p><p><strong>Methods: </strong>This study recruited participants from the Department of Neurology and Rehabilitation Medicine at Shunde Hospital, Southern Medical University. The Fugl-Meyer Assessment was used to assess functional impairment. Serum irisin levels were measured using the enzyme-linked immunosorbent assay method. Multivariate logistic regression was employed to explore the factors related to serum irisin levels and AIS.</p><p><strong>Results: </strong>Serum irisin levels in the AIS group were significantly lower than those in the control group. However, no significant association was observed between serum irisin and stroke severity within the AIS cohort. Multivariate logistic regression analysis revealed an inverse correlation between serum irisin levels and AIS risk, indicating that it serves as a protective factor against AIS. The increase in serum irisin levels (adjusted odds ratio (OR) 0.938, 95% confidence interval [CI]: 0.899-0.977 per 100 pg/mL increment) was associated with a decreased risk of AIS. Analysis of the receiver operating characteristic curve confirmed the diagnostic value of serum irisin for AIS, with the area under the curve being 0.591 (95% CI: 0.522-0.659, <i>p</i> = 0.012).</p><p><strong>Conclusion: </strong>Serum irisin levels were significantly lower in AIS and were identified as a protective factor, suggesting that serum irisin may have diagnostic value for AIS.</p>","PeriodicalId":14131,"journal":{"name":"International Journal of General Medicine","volume":"17 ","pages":"5273-5284"},"PeriodicalIF":2.1,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11575442/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142675756","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic Value of Serum Ficolin-3 and Gal-3 in Sepsis Complicated with Acute Kidney Injury. 血清 Ficolin-3 和 Gal-3 在败血症并发急性肾损伤中的诊断价值
IF 2.1 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-15 eCollection Date: 2024-01-01 DOI: 10.2147/IJGM.S478736
Hang Yi, Ruiping Ye, Jinfeng Wang, Lin Gao, Weiwei Zhang, Chao Liu

Objective: To investigate the diagnostic value of serum fibrinogen domain-containing lectin-3 (Ficolin-3) and galectin-3 (Gal-3) in sepsis-associated acute kidney injury (SA-AKI).

Methods: This study retrospectively analyzed 126 SA-AKI patients with SA-AKI and 103 septic patients without AKI as controls. Based on the severity of renal injury, the SA-AKI patients were divided into three groups: mild (41 cases), moderate (53 cases), and severe (32 cases). Serum levels of Ficolin-3 and Gal-3 were measured using ELISA, and their correlation was determined through Pearson analysis. Multivariate logistic regression was used to identify factors associated with the occurrence of SA-AKI.

Results: The serum creatinine (SCr), blood urea nitrogen (BUN), as well as the expression levels of serum Ficolin-3 and Gal-3 in the SA-AKI group were higher than those in the non SA-AKI group (P<0.05). The expression levels of Ficolin-3 and Gal-3 in the serum of the SA-AKI group were also higher than those of the non SA-AKI group (P<0.05). The expression levels of Ficolin-3 and Gal-3 in serum gradually increased with the severity of renal injury in SA-AKI patients (P<0.05). The expression levels of Ficolin-3 and Gal-3 in serum were greatly positively correlated (P<0.001). Elevated levels of BUN, Ficolin-3, and Gal-3 were risk factors affecting the occurrence of SA-AKI (P<0.05). The area under the curve (AUC) of serum Ficolin-3 and Gal-3 for individual diagnosis of SA-AKI was 0.877 and 0.867, respectively, the AUC of their combined diagnosis was 0.953, and the diagnostic sensitivity was higher than that of their individual diagnosis (P<0.001).

Conclusion: The expression levels of serum Ficolin-3 and Gal-3 are closely related to associated with the onset and progression of SA-AKI and hold diagnostic value for its detection. Furthermore, the combined use of both markers provides a more accurate diagnosis than either marker alone.

目的探讨血清含纤维蛋白原结构域凝集素-3(Ficolin-3)和半凝集素-3(Gal-3)在脓毒症相关急性肾损伤(SA-AKI)中的诊断价值:本研究回顾性分析了126例脓毒症相关性急性肾损伤(SA-AKI)患者,并以103例无AKI的脓毒症患者作为对照。根据肾损伤的严重程度,SA-AKI 患者被分为三组:轻度(41 例)、中度(53 例)和重度(32 例)。采用 ELISA 法测定血清中 Ficolin-3 和 Gal-3 的水平,并通过 Pearson 分析确定两者的相关性。采用多变量逻辑回归确定与 SA-AKI 发生相关的因素:结果:SA-AKI 组的血清肌酐(SCr)、血尿素氮(BUN)以及血清 Ficolin-3 和 Gal-3 的表达水平均高于非 SA-AKI 组(PConclusion:血清Ficolin-3和Gal-3的表达水平与SA-AKI的发病和进展密切相关,具有诊断价值。此外,联合使用这两种标记物比单独使用其中一种标记物能提供更准确的诊断。
{"title":"Diagnostic Value of Serum Ficolin-3 and Gal-3 in Sepsis Complicated with Acute Kidney Injury.","authors":"Hang Yi, Ruiping Ye, Jinfeng Wang, Lin Gao, Weiwei Zhang, Chao Liu","doi":"10.2147/IJGM.S478736","DOIUrl":"10.2147/IJGM.S478736","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the diagnostic value of serum fibrinogen domain-containing lectin-3 (Ficolin-3) and galectin-3 (Gal-3) in sepsis-associated acute kidney injury (SA-AKI).</p><p><strong>Methods: </strong>This study retrospectively analyzed 126 SA-AKI patients with SA-AKI and 103 septic patients without AKI as controls. Based on the severity of renal injury, the SA-AKI patients were divided into three groups: mild (41 cases), moderate (53 cases), and severe (32 cases). Serum levels of Ficolin-3 and Gal-3 were measured using ELISA, and their correlation was determined through Pearson analysis. Multivariate logistic regression was used to identify factors associated with the occurrence of SA-AKI.</p><p><strong>Results: </strong>The serum creatinine (SCr), blood urea nitrogen (BUN), as well as the expression levels of serum Ficolin-3 and Gal-3 in the SA-AKI group were higher than those in the non SA-AKI group (P<0.05). The expression levels of Ficolin-3 and Gal-3 in the serum of the SA-AKI group were also higher than those of the non SA-AKI group (P<0.05). The expression levels of Ficolin-3 and Gal-3 in serum gradually increased with the severity of renal injury in SA-AKI patients (P<0.05). The expression levels of Ficolin-3 and Gal-3 in serum were greatly positively correlated (P<0.001). Elevated levels of BUN, Ficolin-3, and Gal-3 were risk factors affecting the occurrence of SA-AKI (P<0.05). The area under the curve (AUC) of serum Ficolin-3 and Gal-3 for individual diagnosis of SA-AKI was 0.877 and 0.867, respectively, the AUC of their combined diagnosis was 0.953, and the diagnostic sensitivity was higher than that of their individual diagnosis (P<0.001).</p><p><strong>Conclusion: </strong>The expression levels of serum Ficolin-3 and Gal-3 are closely related to associated with the onset and progression of SA-AKI and hold diagnostic value for its detection. Furthermore, the combined use of both markers provides a more accurate diagnosis than either marker alone.</p>","PeriodicalId":14131,"journal":{"name":"International Journal of General Medicine","volume":"17 ","pages":"5299-5307"},"PeriodicalIF":2.1,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11577257/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142681652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immune-Related Genes Associated with Interstitial Lung Disease in Dermatomyositis. 与皮肌炎间质性肺病相关的免疫相关基因
IF 2.1 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-14 eCollection Date: 2024-01-01 DOI: 10.2147/IJGM.S490294
Changjian Liu, Yongpeng Ge

Background: Interstitial lung disease (ILD) is one of the significant complications of dermatomyositis (DM), but the mechanisms by which it occurs remain incompletely elucidated. This study aimed to explore further the possible genetic mechanisms by which this complication occurs.

Methods: Gene expression profiles for DM (GSE39454, GSE46239, GSE143323) and ILD (GSE32537, GSE110147, GSE150910) were downloaded from the Gene Expression Omnibus (GEO) database. After identifying common differentially expressed genes (DEGs) to DM and ILD using the "limma" R package and the "VennDiagram" R package, functional annotation, relationship to immune cell infiltration, identification of transcription factors (TFs), we also collected clinical cases of DM-associated ILD (DM-ILD), including 3 cases of rapidly progressive ILD (RP-ILD) and 3 cases of none-RP-ILD, and explored whether there were differences in serum lymphocyte subpopulations.

Results: A total of 4 common DEGs (SLAMF7, SPP1, TDO2, and VCAM1) were screened and Gene Ontology (GO) enrichment analysis showed that these genes were mainly enriched in T cell activation, regulation of lymphocyte activation, lymphocyte differentiation, leukocyte proliferation and regulation of T cell activation. In terms of Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways, the three significantly enriched pathways were the PI3K-Akt signaling pathway, MAPK signaling pathway, and Cytokine-cytokine receptor interaction. In lung and muscle tissues, 21 and 3 TFs may regulate the expression of these genes, respectively. Finally, by analysing the serum lymphocyte subpopulations, we also found a decrease in the absolute number of CD8+ T cells and an increase in the CD4+ /CD8+ T cell ratio in DM combined with RP-ILD.

Conclusion: These common pathways and key genes may provide new ideas for further research into DM-ILD.

背景:间质性肺病(ILD)是皮肌炎(DM)的重要并发症之一,但其发生机制仍未完全阐明。本研究旨在进一步探讨发生这种并发症的可能遗传机制:从基因表达总库(GEO)数据库中下载了 DM(GSE39454、GSE46239、GSE143323)和 ILD(GSE32537、GSE110147、GSE150910)的基因表达谱。在利用 "limma "R软件包和 "VennDiagram "R软件包识别了DM和ILD的常见差异表达基因(DEGs)、功能注释、与免疫细胞浸润的关系、转录因子(TFs)的鉴定之后,我们还收集了DM相关ILD(DM-ILD)的临床病例,包括3例快速进展性ILD(RP-ILD)和3例非RP-ILD,并探讨了血清淋巴细胞亚群是否存在差异:结果:共筛选出4个常见的DEGs(SLAMF7、SPP1、TDO2和VCAM1),基因本体(GO)富集分析表明,这些基因主要富集于T细胞活化、淋巴细胞活化调控、淋巴细胞分化、白细胞增殖和T细胞活化调控。在《京都基因组百科全书》(KEGG)通路方面,显著富集的三个通路分别是 PI3K-Akt 信号通路、MAPK 信号通路和细胞因子-细胞因子受体相互作用。在肺组织和肌肉组织中,分别有 21 个和 3 个 TFs 可调控这些基因的表达。最后,通过分析血清淋巴细胞亚群,我们还发现在 DM 合并 RP-ILD 患者中,CD8+ T 细胞的绝对数量减少,CD4+/CD8+ T 细胞的比例增加:这些共同通路和关键基因可能为进一步研究 DM-ILD 提供了新思路。
{"title":"Immune-Related Genes Associated with Interstitial Lung Disease in Dermatomyositis.","authors":"Changjian Liu, Yongpeng Ge","doi":"10.2147/IJGM.S490294","DOIUrl":"10.2147/IJGM.S490294","url":null,"abstract":"<p><strong>Background: </strong>Interstitial lung disease (ILD) is one of the significant complications of dermatomyositis (DM), but the mechanisms by which it occurs remain incompletely elucidated. This study aimed to explore further the possible genetic mechanisms by which this complication occurs.</p><p><strong>Methods: </strong>Gene expression profiles for DM (GSE39454, GSE46239, GSE143323) and ILD (GSE32537, GSE110147, GSE150910) were downloaded from the Gene Expression Omnibus (GEO) database. After identifying common differentially expressed genes (DEGs) to DM and ILD using the \"limma\" R package and the \"VennDiagram\" R package, functional annotation, relationship to immune cell infiltration, identification of transcription factors (TFs), we also collected clinical cases of DM-associated ILD (DM-ILD), including 3 cases of rapidly progressive ILD (RP-ILD) and 3 cases of none-RP-ILD, and explored whether there were differences in serum lymphocyte subpopulations.</p><p><strong>Results: </strong>A total of 4 common DEGs (SLAMF7, SPP1, TDO2, and VCAM1) were screened and Gene Ontology (GO) enrichment analysis showed that these genes were mainly enriched in T cell activation, regulation of lymphocyte activation, lymphocyte differentiation, leukocyte proliferation and regulation of T cell activation. In terms of Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways, the three significantly enriched pathways were the PI3K-Akt signaling pathway, MAPK signaling pathway, and Cytokine-cytokine receptor interaction. In lung and muscle tissues, 21 and 3 TFs may regulate the expression of these genes, respectively. Finally, by analysing the serum lymphocyte subpopulations, we also found a decrease in the absolute number of CD8+ T cells and an increase in the CD4+ /CD8+ T cell ratio in DM combined with RP-ILD.</p><p><strong>Conclusion: </strong>These common pathways and key genes may provide new ideas for further research into DM-ILD.</p>","PeriodicalId":14131,"journal":{"name":"International Journal of General Medicine","volume":"17 ","pages":"5261-5271"},"PeriodicalIF":2.1,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11573690/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142675750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Maternal and Neonatal Perinatal Outcomes of Singleton Pregnancies in Advanced-Age Women Undergoing IVF/ICSI-ET Compared with Spontaneous Conception: A Retrospective Propensity Score Matched Cohort Study. 与自然受孕相比,接受试管婴儿/ICSI-ET 的高龄产妇单胎妊娠的母体和新生儿围产期结局:倾向得分匹配队列回顾性研究》。
IF 2.1 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-13 eCollection Date: 2024-01-01 DOI: 10.2147/IJGM.S490959
Jingxia Mao, Guibo Yang, Qin Su, Zhonghong Zeng, Jueying Lin, Lin Kong, Lidun Zhang, Lidan Liu, Yihua Yang, Hongbo Wu

Objective: To assess the safety and efficiency of in vitro fertilization/ intracytoplasmic sperm injection and embryo transfer (IVF/ICSI-ET) on maternal and neonatal perinatal outcomes in women (≥40y) with singleton pregnancies.

Methods: This multi-center retrospective cohort study, carried out from January 2018 to June 2023, enrolled 1762 women (≥40y) with singleton pregnancies of at least 28 weeks. Participants were divided into two groups: the IVF/ICSI-ET group (204 cases) and the spontaneous conception (SC) group (1558 cases). After 1:2 propensity score matching (PSM), the two groups were compared for maternal and neonatal outcomes. The SC group (1558 cases) was further divided by age into the <43 years group (1195 cases) and the ≥43 years group (363 cases) for subgroup analysis.

Results: Adverse maternal and neonatal outcomes were comparable between the IVF/ICSI-ET group and the SC group, with a higher cesarean section rate (78% vs 67.5%, P =0.013), an increased maternal ICU admissions rate (5.5% vs 1.3%, P =0.008), and a lower birth defects rate (1.1% vs 4.6%, P =0.037) in the IVF/ICSI-ET group. Subgroup analysis showed that women aged ≥43 years had higher incidences of gestational diabetes, gestational hypertension, cesarean section, and neonatal asphyxia compared to women aged <43 years.

Conclusion: This study indicated IVF/ICSI-ET is relatively safe for women ≥40 years with singleton pregnancies. However, advanced maternal age deteriorated maternal and neonatal outcomes, and IVF/ICSI-ET further heightened the risk of cesarean section and maternal ICU admissions. Therefore, enhanced care and vigilance are crucial for women over 40 undergoing IVF/ICSI-ET.

目的评估体外受精/卵胞浆内单精子显微注射和胚胎移植(IVF/ICSI-ET)对单胎妊娠妇女(≥40y)的孕产妇和新生儿围产期结局的安全性和有效性:这项多中心回顾性队列研究于2018年1月至2023年6月进行,共招募了1762名妊娠至少28周的单胎妊娠妇女(≥40岁)。参与者分为两组:IVF/ICSI-ET组(204例)和自然受孕(SC)组(1558例)。经过 1:2 倾向评分匹配(PSM)后,两组的产妇和新生儿结局进行了比较。自然受孕组(1558 例)再按年龄分为结果组:IVF/ICSI-ET组与SC组的产妇和新生儿不良结局相当,IVF/ICSI-ET组的剖宫产率较高(78% vs 67.5%,P =0.013),产妇入住ICU的比例增加(5.5% vs 1.3%,P =0.008),出生缺陷率较低(1.1% vs 4.6%,P =0.037)。亚组分析表明,与结论年龄的妇女相比,年龄≥43 岁的妇女妊娠糖尿病、妊娠高血压、剖宫产和新生儿窒息的发生率更高:本研究表明,IVF/ICSI-ET 对年龄≥40 岁的单胎妊娠妇女相对安全。然而,高龄产妇会导致产妇和新生儿预后恶化,IVF/ICSI-ET 进一步增加了剖宫产和产妇入住重症监护室的风险。因此,对于 40 岁以上接受体外受精/卵胞浆内单精子显微注射(IVF/ICSI-ET)的妇女来说,加强护理和提高警惕至关重要。
{"title":"Maternal and Neonatal Perinatal Outcomes of Singleton Pregnancies in Advanced-Age Women Undergoing IVF/ICSI-ET Compared with Spontaneous Conception: A Retrospective Propensity Score Matched Cohort Study.","authors":"Jingxia Mao, Guibo Yang, Qin Su, Zhonghong Zeng, Jueying Lin, Lin Kong, Lidun Zhang, Lidan Liu, Yihua Yang, Hongbo Wu","doi":"10.2147/IJGM.S490959","DOIUrl":"10.2147/IJGM.S490959","url":null,"abstract":"<p><strong>Objective: </strong>To assess the safety and efficiency of in vitro fertilization/ intracytoplasmic sperm injection and embryo transfer (IVF/ICSI-ET) on maternal and neonatal perinatal outcomes in women (≥40y) with singleton pregnancies.</p><p><strong>Methods: </strong>This multi-center retrospective cohort study, carried out from January 2018 to June 2023, enrolled 1762 women (≥40y) with singleton pregnancies of at least 28 weeks. Participants were divided into two groups: the IVF/ICSI-ET group (204 cases) and the spontaneous conception (SC) group (1558 cases). After 1:2 propensity score matching (PSM), the two groups were compared for maternal and neonatal outcomes. The SC group (1558 cases) was further divided by age into the <43 years group (1195 cases) and the ≥43 years group (363 cases) for subgroup analysis.</p><p><strong>Results: </strong>Adverse maternal and neonatal outcomes were comparable between the IVF/ICSI-ET group and the SC group, with a higher cesarean section rate (78% vs 67.5%, P =0.013), an increased maternal ICU admissions rate (5.5% vs 1.3%, P =0.008), and a lower birth defects rate (1.1% vs 4.6%, P =0.037) in the IVF/ICSI-ET group. Subgroup analysis showed that women aged ≥43 years had higher incidences of gestational diabetes, gestational hypertension, cesarean section, and neonatal asphyxia compared to women aged <43 years.</p><p><strong>Conclusion: </strong>This study indicated IVF/ICSI-ET is relatively safe for women ≥40 years with singleton pregnancies. However, advanced maternal age deteriorated maternal and neonatal outcomes, and IVF/ICSI-ET further heightened the risk of cesarean section and maternal ICU admissions. Therefore, enhanced care and vigilance are crucial for women over 40 undergoing IVF/ICSI-ET.</p>","PeriodicalId":14131,"journal":{"name":"International Journal of General Medicine","volume":"17 ","pages":"5249-5259"},"PeriodicalIF":2.1,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11569707/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142647255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serum microRNA-181a Expression Level in Patients with Acute Liver Failure and Its Correlation with Prognosis [Letter]. 急性肝衰竭患者血清 microRNA-181a 表达水平及其与预后的相关性 [信].
IF 2.1 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-13 eCollection Date: 2024-01-01 DOI: 10.2147/IJGM.S503175
Isak Roberth Akollo
{"title":"Serum microRNA-181a Expression Level in Patients with Acute Liver Failure and Its Correlation with Prognosis [Letter].","authors":"Isak Roberth Akollo","doi":"10.2147/IJGM.S503175","DOIUrl":"10.2147/IJGM.S503175","url":null,"abstract":"","PeriodicalId":14131,"journal":{"name":"International Journal of General Medicine","volume":"17 ","pages":"5247-5248"},"PeriodicalIF":2.1,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11569702/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142647281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Narrative Review of Impact of Incentive Spirometer Respiratory Training in Long COVID. 激励式肺活量计呼吸训练对长期 COVID 影响的叙述性综述。
IF 2.1 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-13 eCollection Date: 2024-01-01 DOI: 10.2147/IJGM.S492772
Yao-Hsiang Chen, Yu-Shan Hsieh

Long COVID refers to symptoms that appear 3 months after initial infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative virus of Coronavirus disease 2019 (COVID-19), and last for at least 2 months, not attributable to other diagnoses. This health issue significantly burdens patients' quality of life, the economy, and society. Improving the af-termath of COVID-19 is a crucial global health issue in the post-pandemic era. According to current results, it is evident that developing a simple, low-cost respiratory training method that can be easily used at home by themselves with long Coronavirus disease 2019 symptoms (long COVID) is an important and urgent issue. The incentive spirometer is widely used in physical, speech, and respiratory therapy, as well as in preventing postoperative pulmonary infections and improving sputum clearance. However, to date, the role of incentive spirometer respiratory training in long COVID symptoms is still limited. In this literature review is presented to explore the effectiveness of incentive spirometer respiratory training in alleviating symptoms among individuals recovering from long COVID. We also compile non-invasive assessment methods, with the aim to enable individuals to undergo training and assessments conveniently at home or in the community. In this review, a literature review approach was utilized to explore the effectiveness of incentive spirometer intervention in alleviating long-term COVID symptoms. This study is to synthesize the findings of articles published during January 2019 and December 2023 retrieved from PubMed/CINAHL/MEDLINE/ Google Scholar without re-strictions on study type. We ultimately identified seven articles and have summarized similar past studies. This review could contribute to improving symptoms related to long COVID by incentive spirometer respiratory training and serve as practical reference material for clinical medical staff and provide insights for healthcare policymakers in de-veloping guidelines for future research directions, clinical guidance, and educational strategies in the context of nursing care.

长病程冠状病毒病是指在初次感染严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)(2019 年冠状病毒病(COVID-19)的致病病毒)3 个月后出现症状,并持续至少 2 个月,且不能归因于其他诊断。这一健康问题严重影响了患者的生活质量、经济和社会。在后流行病时代,改善 COVID-19 的后期病程是一个至关重要的全球健康问题。根据目前的研究结果,开发一种简单、低成本的呼吸训练方法,让2019年冠状病毒病(长COVID)患者在家中就能轻松使用,显然是一个重要而紧迫的问题。激励肺活量计广泛应用于物理、语言和呼吸治疗,以及预防术后肺部感染和提高痰液清除率。然而,迄今为止,激励式肺活量计呼吸训练在长期 COVID 症状中的作用仍然有限。本篇文献综述旨在探讨激励式肺活量计呼吸训练在缓解长期 COVID 患者症状方面的有效性。我们还汇编了无创评估方法,目的是让患者能够在家中或社区方便地接受训练和评估。在本综述中,我们采用了文献综述的方法来探讨激励式肺活量计干预对缓解长期 COVID 症状的有效性。本研究将对2019年1月至2023年12月期间发表的文章进行综述,文章检索自PubMed/CINAHL/MEDLINE/谷歌学术,不对研究类型进行再限制。我们最终确定了七篇文章,并对过去的类似研究进行了总结。本综述有助于通过激励式肺活量计呼吸训练改善长COVID相关症状,可作为临床医务人员的实用参考资料,并为医疗政策制定者在护理背景下制定未来研究方向、临床指导和教育策略的指导方针提供启示。
{"title":"A Narrative Review of Impact of Incentive Spirometer Respiratory Training in Long COVID.","authors":"Yao-Hsiang Chen, Yu-Shan Hsieh","doi":"10.2147/IJGM.S492772","DOIUrl":"10.2147/IJGM.S492772","url":null,"abstract":"<p><p>Long COVID refers to symptoms that appear 3 months after initial infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative virus of Coronavirus disease 2019 (COVID-19), and last for at least 2 months, not attributable to other diagnoses. This health issue significantly burdens patients' quality of life, the economy, and society. Improving the af-termath of COVID-19 is a crucial global health issue in the post-pandemic era. According to current results, it is evident that developing a simple, low-cost respiratory training method that can be easily used at home by themselves with long Coronavirus disease 2019 symptoms (long COVID) is an important and urgent issue. The incentive spirometer is widely used in physical, speech, and respiratory therapy, as well as in preventing postoperative pulmonary infections and improving sputum clearance. However, to date, the role of incentive spirometer respiratory training in long COVID symptoms is still limited. In this literature review is presented to explore the effectiveness of incentive spirometer respiratory training in alleviating symptoms among individuals recovering from long COVID. We also compile non-invasive assessment methods, with the aim to enable individuals to undergo training and assessments conveniently at home or in the community. In this review, a literature review approach was utilized to explore the effectiveness of incentive spirometer intervention in alleviating long-term COVID symptoms. This study is to synthesize the findings of articles published during January 2019 and December 2023 retrieved from PubMed/CINAHL/MEDLINE/ Google Scholar without re-strictions on study type. We ultimately identified seven articles and have summarized similar past studies. This review could contribute to improving symptoms related to long COVID by incentive spirometer respiratory training and serve as practical reference material for clinical medical staff and provide insights for healthcare policymakers in de-veloping guidelines for future research directions, clinical guidance, and educational strategies in the context of nursing care.</p>","PeriodicalId":14131,"journal":{"name":"International Journal of General Medicine","volume":"17 ","pages":"5233-5246"},"PeriodicalIF":2.1,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11570525/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142668080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Regulating Lipid Metabolism in Gout: A New Perspective with Therapeutic Potential. 调节痛风中的脂质代谢:具有治疗潜力的新视角。
IF 2.1 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-12 eCollection Date: 2024-01-01 DOI: 10.2147/IJGM.S499413
Xianheng Zhang, Jian Liu

Gout is a metabolic disease characterized by inflammatory arthritis caused by abnormal uric acid metabolism. It is often complicated with cardio-renal damage and vascular lesions. In recent years, the relationship between lipid metabolism and gout has attracted increasing attention. Changes in blood lipids in gout patients are often clinically detectable and closely related to uric acid metabolism and inflammatory response in gout. With the development of lipidomics, the changes in small lipid molecules and their metabolic pathways have been gradually discovered, yielding a greater understanding of the lipid metabolism changes in gout patients and their potential role in gout development. Through searching the literature on lipid metabolism in gout since 2000 in PubMed and Web of Science, this article reviewed lipid metabolism changes in gout patients and their role in the risk of gout, uric acid metabolism, inflammatory response, and comorbidities. Additionally, the strategies to regulate the abnormal lipid metabolism in gout have also been summarized from the aspects of drugs, diet, and exercise. These will provide a new perspective for understanding gout pathogenesis and its treatment and management.

痛风是一种代谢性疾病,其特征是由尿酸代谢异常引起的炎症性关节炎。痛风常并发心肾损害和血管病变。近年来,脂质代谢与痛风之间的关系日益受到关注。痛风患者的血脂变化往往可以在临床上检测到,并且与痛风的尿酸代谢和炎症反应密切相关。随着脂质组学的发展,人们逐渐发现了脂质小分子的变化及其代谢途径,从而对痛风患者的脂质代谢变化及其在痛风发病中的潜在作用有了更深入的了解。通过在 PubMed 和 Web of Science 上检索 2000 年以来有关痛风脂质代谢的文献,本文综述了痛风患者的脂质代谢变化及其在痛风风险、尿酸代谢、炎症反应和合并症中的作用。此外,还从药物、饮食和运动等方面总结了痛风患者脂质代谢异常的调节策略。这些将为了解痛风的发病机制及其治疗和管理提供一个新的视角。
{"title":"Regulating Lipid Metabolism in Gout: A New Perspective with Therapeutic Potential.","authors":"Xianheng Zhang, Jian Liu","doi":"10.2147/IJGM.S499413","DOIUrl":"10.2147/IJGM.S499413","url":null,"abstract":"<p><p>Gout is a metabolic disease characterized by inflammatory arthritis caused by abnormal uric acid metabolism. It is often complicated with cardio-renal damage and vascular lesions. In recent years, the relationship between lipid metabolism and gout has attracted increasing attention. Changes in blood lipids in gout patients are often clinically detectable and closely related to uric acid metabolism and inflammatory response in gout. With the development of lipidomics, the changes in small lipid molecules and their metabolic pathways have been gradually discovered, yielding a greater understanding of the lipid metabolism changes in gout patients and their potential role in gout development. Through searching the literature on lipid metabolism in gout since 2000 in PubMed and Web of Science, this article reviewed lipid metabolism changes in gout patients and their role in the risk of gout, uric acid metabolism, inflammatory response, and comorbidities. Additionally, the strategies to regulate the abnormal lipid metabolism in gout have also been summarized from the aspects of drugs, diet, and exercise. These will provide a new perspective for understanding gout pathogenesis and its treatment and management.</p>","PeriodicalId":14131,"journal":{"name":"International Journal of General Medicine","volume":"17 ","pages":"5203-5217"},"PeriodicalIF":2.1,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11568860/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142647343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Low Prognostic Nutritional Index (PNI) Level is Associated with an Increased Risk of Neonatal Respiratory Distress Syndrome in Preterm Infants with Different Gestational Ages: A Retrospective Study. 低预后营养指数(PNI)水平与不同胎龄早产儿患新生儿呼吸窘迫综合征的风险增加有关:一项回顾性研究。
IF 2.1 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-12 eCollection Date: 2024-01-01 DOI: 10.2147/IJGM.S486224
Liudan Huang, Xuexin Chen, Yuhua Zhang

Background: Neonatal respiratory distress syndrome (NRDS) is common in preterm infants. Prognostic nutritional index (PNI)((albumin (g/L)+(5×total lymphocyte count (109/L)) is a comprehensive indicator of nutritional and immune levels, and associated with several diseases. The relationship between PNI and the risk of NRDS in newborns of different gestational ages remains unclear.

Methods: A total of 2722 preterm infants were included in this retrospective study. PNI level and clinical records of these neonates (adverse pregnancy and birth history, amniotic fluid contamination, nuchal cord, placental abnormality, mode of delivery, gender and birth weight of neonates, Apgar scores) were collected. The clinical features of the infants with and without NRDS were compared. Logistic regression analysis was used to evaluate the relationship between PNI and NRDS in newborns with different gestational ages.

Results: There were 1226 neonates with NRDS and 1496 without NRDS. The differences in the proportions of placenta abnormality, cesarean section, and small for gestational age (SGA) among infants with 34-37 weeks, 28+1-33+6 weeks, and ≤28 weeks gestational age were statistically significant. Logistic analysis showed that cesarean section (odds ratio (OR): 1.550, 95% confidence interval (CI): 1.197-2.007, p=0.001), and low PNI (OR: 1.417, 95% CI: 1.110-1.808, p=0.005) were associated with NRDS in infants born at 34-37 weeks gestational. Adverse pregnancy and birth history (OR: 1.507, 95% CI: 1.124-2.019, p=0.006), SGA (OR: 1.994, 95% CI: 1.455-2.733, p<0.001), and low PNI (OR: 1.626, 95% CI: 1.230-2.149, p=0.001) were associated with NRDS in infants with 28+1-33+6 weeks gestational age. Low PNI (OR: 5.512, 95% CI: 1.555-19.536, p=0.008) was associated with NRDS in infants with ≤28 weeks gestational age.

Conclusion: The risk factors for NRDS in preterm infants with different gestational ages were different. But the low PNI level is associated with an increased risk of NRDS in preterm infants with all different gestational ages.

背景:新生儿呼吸窘迫综合征(NRDS)常见于早产儿。预后营养指数(PNI)((白蛋白(g/L)+(5×总淋巴细胞计数(109/L))是营养和免疫水平的综合指标,与多种疾病相关。不同胎龄新生儿的 PNI 与 NRDS 风险之间的关系仍不清楚:这项回顾性研究共纳入了 2722 名早产儿。收集了这些新生儿的 PNI 水平和临床记录(不良妊娠和分娩史、羊水污染、脐带、胎盘异常、分娩方式、新生儿性别和出生体重、Apgar 评分)。对患有和未患有 NRDS 的婴儿的临床特征进行了比较。采用逻辑回归分析评估不同胎龄新生儿的 PNI 与 NRDS 之间的关系:结果:1226 名新生儿患有 NRDS,1496 名未患有 NRDS。胎龄在 34-37 周、28+1-33+6 周和≤28 周的新生儿中,胎盘异常、剖宫产和小于胎龄(SGA)的比例差异有统计学意义。逻辑分析显示,剖宫产(几率比(OR):1.550,95% 置信区间(CI):1.197-2.007,P=0.001)和低 PNI(OR:1.417,95% CI:1.110-1.808,P=0.005)与胎龄 34-37 周出生婴儿的 NRDS 相关。不良孕产史(OR:1.507,95% CI:1.124-2.019,p=0.006)、SGA(OR:1.994,95% CI:1.455-2.733,pp=0.001)与孕龄 28+1-33+6 周婴儿的 NRDS 相关。胎龄≤28周的婴儿中,低PNI(OR:5.512,95% CI:1.555-19.536,P=0.008)与NRDS相关:结论:不同胎龄的早产儿发生 NRDS 的风险因素不同。结论:不同胎龄的早产儿发生 NRDS 的风险因素不同,但 PNI 水平低与所有不同胎龄的早产儿发生 NRDS 的风险增加有关。
{"title":"Low Prognostic Nutritional Index (PNI) Level is Associated with an Increased Risk of Neonatal Respiratory Distress Syndrome in Preterm Infants with Different Gestational Ages: A Retrospective Study.","authors":"Liudan Huang, Xuexin Chen, Yuhua Zhang","doi":"10.2147/IJGM.S486224","DOIUrl":"10.2147/IJGM.S486224","url":null,"abstract":"<p><strong>Background: </strong>Neonatal respiratory distress syndrome (NRDS) is common in preterm infants. Prognostic nutritional index (PNI)((albumin (g/L)+(5×total lymphocyte count (10<sup>9</sup>/L)) is a comprehensive indicator of nutritional and immune levels, and associated with several diseases. The relationship between PNI and the risk of NRDS in newborns of different gestational ages remains unclear.</p><p><strong>Methods: </strong>A total of 2722 preterm infants were included in this retrospective study. PNI level and clinical records of these neonates (adverse pregnancy and birth history, amniotic fluid contamination, nuchal cord, placental abnormality, mode of delivery, gender and birth weight of neonates, Apgar scores) were collected. The clinical features of the infants with and without NRDS were compared. Logistic regression analysis was used to evaluate the relationship between PNI and NRDS in newborns with different gestational ages.</p><p><strong>Results: </strong>There were 1226 neonates with NRDS and 1496 without NRDS. The differences in the proportions of placenta abnormality, cesarean section, and small for gestational age (SGA) among infants with 34-37 weeks, 28<sup>+1</sup>-33<sup>+6</sup> weeks, and ≤28 weeks gestational age were statistically significant. Logistic analysis showed that cesarean section (odds ratio (OR): 1.550, 95% confidence interval (CI): 1.197-2.007, <i>p</i>=0.001), and low PNI (OR: 1.417, 95% CI: 1.110-1.808, <i>p</i>=0.005) were associated with NRDS in infants born at 34-37 weeks gestational. Adverse pregnancy and birth history (OR: 1.507, 95% CI: 1.124-2.019, <i>p</i>=0.006), SGA (OR: 1.994, 95% CI: 1.455-2.733, <i>p</i><0.001), and low PNI (OR: 1.626, 95% CI: 1.230-2.149, <i>p</i>=0.001) were associated with NRDS in infants with 28<sup>+1</sup>-33<sup>+6</sup> weeks gestational age. Low PNI (OR: 5.512, 95% CI: 1.555-19.536, <i>p</i>=0.008) was associated with NRDS in infants with ≤28 weeks gestational age.</p><p><strong>Conclusion: </strong>The risk factors for NRDS in preterm infants with different gestational ages were different. But the low PNI level is associated with an increased risk of NRDS in preterm infants with all different gestational ages.</p>","PeriodicalId":14131,"journal":{"name":"International Journal of General Medicine","volume":"17 ","pages":"5219-5231"},"PeriodicalIF":2.1,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11568769/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142647252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of General Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1